Latest Regulatory Approvals News

Page 7 of 191
Immutep Limited reports robust progress in its pivotal Phase III TACTI-004 trial for advanced non-small cell lung cancer, with over 120 clinical sites activated across 27 countries including the US. Patient enrolment has reached 38% of the target, keeping key milestones on track.
Ada Torres
Ada Torres
16 Dec 2025
Li-FT Power Ltd has announced a strategic acquisition of Winsome Resources Limited and plans to acquire a controlling interest in the Galinée lithium property, aiming to create a leading Canadian lithium developer with enhanced scale and market presence.
Maxwell Dee
Maxwell Dee
15 Dec 2025
Zeus Resources has secured Forestry Department approval to begin trenching at its Casablanca Antimony Project in Morocco, clearing a key regulatory hurdle for exploration. The program aims to refine geological understanding and target high-grade antimony mineralization.
Maxwell Dee
Maxwell Dee
15 Dec 2025
4DMedical has gained Canadian regulatory approval for its innovative CT – VQ™ ventilation-perfusion imaging technology, enabling immediate commercial rollout through Philips and expanding its North American footprint.
Ada Torres
Ada Torres
15 Dec 2025
Echelon Resources has signed a term sheet with the Northern Territory’s Power and Water Corporation to supply gas through 2034, including plans for four new wells that could significantly increase output from the Amadeus Basin.
Maxwell Dee
Maxwell Dee
15 Dec 2025
Radiopharm Theranostics reports promising interim Phase 2b results for RAD 101, achieving 92% concordance with MRI in detecting brain metastases, paving the way for a pivotal study in 2026.
Ada Torres
Ada Torres
15 Dec 2025
Diatreme Resources has submitted the Draft Environmental Impact Statement for its Northern Silica Project, marking a significant step toward regulatory approval and highlighting its potential to boost regional economies and support global solar energy growth.
Maxwell Dee
Maxwell Dee
15 Dec 2025
Prescient Therapeutics has secured European authorization to initiate a Phase 2a clinical trial of its novel cancer drug PTX-100 for relapsed/refractory Cutaneous T-cell Lymphoma, enabling trial site activation in Italy.
Ada Torres
Ada Torres
15 Dec 2025
Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.
Ada Torres
Ada Torres
15 Dec 2025
Electro Optic Systems has inked a conditional US$80 million contract to supply a 100kW high energy laser weapon to a South Korean customer, marking its second major export order in this advanced defence technology.
Victor Sage
Victor Sage
15 Dec 2025
Fortescue Ltd has announced a binding agreement to acquire the remaining 64% of Alta Copper, gaining full control of the Cañariaco Copper Project in Peru. The deal values Alta Copper at C$139 million and aligns with Fortescue’s expanding copper strategy.
Maxwell Dee
Maxwell Dee
15 Dec 2025
Finder Energy has completed the acquisition of the Petrojarl I FPSO, gaining full control of vital infrastructure for the Kuda Tasi and Jahal project and setting the stage for a Final Investment Decision by mid-2026.
Maxwell Dee
Maxwell Dee
15 Dec 2025